Growth Metrics

Catalyst Pharmaceuticals (CPRX) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.12%
Dec 31, 2025 3.70%
Sep 30, 2025 7.50%
Jun 30, 2025 7.77%
Mar 31, 2025 9.16%
Dec 31, 2024 10.09%
Sep 30, 2024 8.59%
Jun 30, 2024 8.42%
Mar 31, 2024 44.74%
Dec 31, 2023 11.28%
Sep 30, 2023 -7.13%
Jun 30, 2023 12.48%
Mar 31, 2023 11.06%
Dec 31, 2022 11.25%
Sep 30, 2022 12.01%
Jun 30, 2022 9.48%
Mar 31, 2022 6.47%
Dec 31, 2021 4.11%
Sep 30, 2021 5.14%
Jun 30, 2021 5.76%
Mar 31, 2021 5.34%
Dec 31, 2020 8.28%
Sep 30, 2020 40.85%
Jun 30, 2020 11.56%
Mar 31, 2020 13.75%
Dec 31, 2019 12.37%
Sep 30, 2019 23.23%
Jun 30, 2019 23.66%
Mar 31, 2019 0.77%
Dec 31, 2018 -20.74%
Sep 30, 2018 -9.83%
Jun 30, 2018 -6.80%
Mar 31, 2018 -5.83%
Dec 31, 2017 155.17%
Sep 30, 2017 -6.59%
Jun 30, 2017 -3.21%
Mar 31, 2017 -10.72%
Dec 31, 2016 -8.38%
Sep 30, 2016 -7.39%
Jun 30, 2016 -8.33%
Mar 31, 2016 -8.90%
Dec 31, 2015 -8.53%
Sep 30, 2015 -3.41%
Jun 30, 2015 -5.75%
Mar 31, 2015 89.04%
Dec 31, 2014 -3.77%
Sep 30, 2014 -11.08%
Jun 30, 2014 133.51%
Mar 31, 2014 -17.54%
Dec 31, 2013 -3.29%
Sep 30, 2013 124.69%
Mar 31, 2012 -27.76%
Dec 31, 2011 -2.95%
Sep 30, 2011 -21.78%